INTRODUCTION: Standardization of care can reduce practice variation, optimize resource utilization, and improve clinical outcomes. We have created a standardized clinical assessment and management plan (SCAMP) for patients having balloon aortic valvuloplasty (BAV) for congenital aortic stenosis (AS). This study compares acute outcomes of BAV at our institution before and after introduction of this SCAMP. METHODS: In this retrospective matched cohort study, each SCAMP patient was matched to four historical controls. Outcomes were categorized based on the combination of residual AS and aortic regurgitation (AR) as: (1) Optimal: gradient ≤ 35 mm Hg and trivial or no AR; (2) Adequate: gradient ≤ 35 mm Hg and mild AR; (3) Inadequate: gradient > 35 mm Hg and/or moderate or severe AR. RESULTS: All 23 SCAMP patients achieved a residual AS gradient ≤ 35 mm Hg; the median residual AS gradient for the SCAMP group was lower (25 [10-35] mm Hg) than in matched controls (30 [0-65] mm Hg; P = 0.005). The two groups did not differ with regard to degree of AR grade after BAV. Compared with controls, SCAMP patients were more likely to have an optimal result and less likely to have an inadequate result (52% vs. 34% and 17% vs. 45%, respectively; P = 0.02) CONCLUSIONS: A SCAMP for BAV resulted in optimal acute results in half of the initial 23 patients enrolled, and outcomes in this group were better than those of matched historical controls. Whether these improved acute outcomes translate into better long-term outcomes for this patient population remains to be seen.
INTRODUCTION: Standardization of care can reduce practice variation, optimize resource utilization, and improve clinical outcomes. We have created a standardized clinical assessment and management plan (SCAMP) for patients having balloon aortic valvuloplasty (BAV) for congenital aortic stenosis (AS). This study compares acute outcomes of BAV at our institution before and after introduction of this SCAMP. METHODS: In this retrospective matched cohort study, each SCAMPpatient was matched to four historical controls. Outcomes were categorized based on the combination of residual AS and aortic regurgitation (AR) as: (1) Optimal: gradient ≤ 35 mm Hg and trivial or no AR; (2) Adequate: gradient ≤ 35 mm Hg and mild AR; (3) Inadequate: gradient > 35 mm Hg and/or moderate or severe AR. RESULTS: All 23 SCAMPpatients achieved a residual AS gradient ≤ 35 mm Hg; the median residual AS gradient for the SCAMP group was lower (25 [10-35] mm Hg) than in matched controls (30 [0-65] mm Hg; P = 0.005). The two groups did not differ with regard to degree of AR grade after BAV. Compared with controls, SCAMPpatients were more likely to have an optimal result and less likely to have an inadequate result (52% vs. 34% and 17% vs. 45%, respectively; P = 0.02) CONCLUSIONS: A SCAMP for BAV resulted in optimal acute results in half of the initial 23 patients enrolled, and outcomes in this group were better than those of matched historical controls. Whether these improved acute outcomes translate into better long-term outcomes for this patient population remains to be seen.
Authors: Carlos Alva; Agustín Sánchez; Felipe David; Santiago Jiménez; David Jiménez; José Ortegén; Martha Hernández; José Antonio Magaña; Rubén Argüero; Mariano Ledesma Journal: Cardiol Young Date: 2002-07 Impact factor: 1.093
Authors: Kevin G Friedman; Rahul H Rathod; Michael Farias; Dionne Graham; Andrew J Powell; David R Fulton; Jane W Newburger; Steven D Colan; Kathy J Jenkins; James E Lock Journal: Congenit Heart Dis Date: 2010 Jul-Aug Impact factor: 2.007
Authors: B W McCrindle; E H Blackstone; W G Williams; R Sittiwangkul; T L Spray; A Azakie; R A Jonas Journal: Circulation Date: 2001-09-18 Impact factor: 29.690
Authors: R S Mosca; M D Iannettoni; S M Schwartz; A Ludomirsky; R H Beekman; T Lloyd; E L Bove Journal: J Thorac Cardiovasc Surg Date: 1995-01 Impact factor: 5.209
Authors: Yvelynne P Kelly; Kavita Mistry; Salman Ahmed; Shimon Shaykevich; Sonali Desai; Stuart R Lipsitz; David E Leaf; Ernest I Mandel; Emily Robinson; Gearoid McMahon; Peter G Czarnecki; David M Charytan; Sushrut S Waikar; Mallika L Mendu Journal: Clin J Am Soc Nephrol Date: 2021-12-15 Impact factor: 8.237
Authors: Claudia A Algaze; Andrew Y Shin; Chealsea Nather; Krisa H Elgin; Chandra Ramamoorthy; Komal Kamra; Alaina K Kipps; Vamsi V Yarlagadda; Monica M Mafla; Tanushree Vashist; Catherine D Krawczeski; Paul J Sharek Journal: Pediatr Qual Saf Date: 2018-10-31
Authors: Fatme A Charafeddine; Haytham Bou Houssein; Nadine B Kibbi; Issam M El-Rassi; Anas M Tabbakh; Mohammad S Abutaqa; Ziad F Bulbul; Nour K Younis; Mariam T Arabi; Fadi F Bitar Journal: J Interv Cardiol Date: 2021-01-12 Impact factor: 2.279